Skip to main content
GILD
NASDAQ Life Sciences

Gilead Finalizes Ouro Medicines Acquisition, Expanding Inflammation Pipeline

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$129.18
Mkt Cap
$160.386B
52W Low
$104.46
52W High
$157.29
52W Position info
24% above low
Off High info
18% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

GILD sits 24% above its 52-week low of $104.46 on elevated volume (1.9× avg).

Summary

Gilead Sciences and Lakefront have completed the acquisition of Ouro Medicines, a move aimed at further expanding Gilead's inflammation pipeline. This finalizes the deal that was initially reported as nearing completion in late March 2026, with a binding agreement announced shortly thereafter. The acquisition strengthens Gilead's strategic focus on its inflammation portfolio.

At the time of this announcement, GILD was trading at $129.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $160.4B. The 52-week trading range was $104.46 to $157.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 06, 2026, 12:16 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $167.82
Real-time Price: $169.10 info
Change: +$1.28 (+0.77%) info
Market Cap: $206.554B info
GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $169.10 info
Change: -$5.47 (-3%) info
Market Cap: $206.554B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $169.10 info
Change: +$3.22 (+2%) info
Market Cap: $206.554B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $169.10 info
Change: +$5.10 (+3%) info
Market Cap: $206.554B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $169.10 info
Change: +$11.91 (+8%) info
Market Cap: $206.554B info